<SEC-DOCUMENT>0001193125-18-081395.txt : 20180314
<SEC-HEADER>0001193125-18-081395.hdr.sgml : 20180314
<ACCEPTANCE-DATETIME>20180314081502
ACCESSION NUMBER:		0001193125-18-081395
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20180314
FILED AS OF DATE:		20180314
DATE AS OF CHANGE:		20180314

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DBV Technologies S.A.
		CENTRAL INDEX KEY:			0001613780
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			I0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36697
		FILM NUMBER:		18688360

	BUSINESS ADDRESS:	
		STREET 1:		177-181 AVENUE PIERRE BROSSOLETTE
		CITY:			MONTROUGE
		STATE:			I0
		ZIP:			92120
		BUSINESS PHONE:		33(0)155427878

	MAIL ADDRESS:	
		STREET 1:		177-181 AVENUE PIERRE BROSSOLETTE
		CITY:			MONTROUGE
		STATE:			I0
		ZIP:			92120
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d551419d6k.htm
<DESCRIPTION>6-K
<TEXT>
<HTML><HEAD>
<TITLE>6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">6-K</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>REPORT OF
FOREIGN PRIVATE ISSUER </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO RULE <FONT STYLE="white-space:nowrap">13a-16</FONT> OR
<FONT STYLE="white-space:nowrap">15d-16</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>UNDER THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the Month of March 2018 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commission File Number: <FONT STYLE="white-space:nowrap">001-36697</FONT> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>DBV TECHNOLOGIES S.A. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Translation of registrant&#146;s name into English) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT
STYLE="white-space:nowrap">177-181</FONT> avenue Pierre Brossolette </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>92120 Montrouge France </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive office) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether
the registrant files or will file annual reports under cover of Form <FONT STYLE="white-space:nowrap">20-F</FONT> or Form <FONT STYLE="white-space:nowrap">40-F:</FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#9746;&nbsp;&nbsp;Form
<FONT STYLE="white-space:nowrap">20-F&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9744;&nbsp;&nbsp;Form</FONT> <FONT STYLE="white-space:nowrap">40-F</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form <FONT STYLE="white-space:nowrap">6-K</FONT> in paper as permitted by Regulation <FONT
STYLE="white-space:nowrap">S-T</FONT> Rule 101(b)(1):&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form <FONT
STYLE="white-space:nowrap">6-K</FONT> in paper as permitted by Regulation <FONT STYLE="white-space:nowrap">S-T</FONT> Rule 101(b)(7):&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT LIST </U></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:25.30pt; display:inline; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Exhibit</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:39.50pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release dated March&nbsp;14, 2018.</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="43%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5"><B>DBV TECHNOLOGIES S.A.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: March&nbsp;14, 2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ David Schilansky</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">David Schilansky</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Deputy Chief Executive Officer</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g551419g22k72.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DBV Technologies Reports Full Year 2017 Financial Results </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DBV Technologies (Euronext: DBV &#150; ISIN: FR0010417345 &#150; Nasdaq Stock Market: DBVT) today announced full year 2017 results. Audit procedures on the
Company&#146;s 2017 consolidated financial statements were completed by the Company&#146;s statutory auditors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cash Position: </B>cash and cash
equivalents as of&nbsp;December 31, 2017,&nbsp;were&nbsp;&#128;137.9&nbsp;million, compared to&nbsp;&#128;256.5 million&nbsp;as of December&nbsp;31, 2016, a decrease of&nbsp;&#128;118.6&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Operating Income: </B>operating income was &#128;11.9&nbsp;million in 2017 compared to &#128;9.1&nbsp;million in 2016, an increase of 31.1%. In 2017,
income was primarily generated from the Company&#146;s Research Tax Credit (Cr&eacute;dit Imp&ocirc;t Recherche) and under the May 2016 collaboration agreement with Nestl&eacute; Health Science. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Research</B><B></B><B>&nbsp;&amp; Development Expenses: </B>research and development expenses increased by&nbsp;&#128;26.4&nbsp;million, or 33.5%, to
&#128;105.2 million&nbsp;in 2017, compared to&nbsp;&#128;78.8 million&nbsp;in 2016, reflecting increased costs associated with the Phase III and Phase II clinical trials of Viaskin Peanut and Viaskin Milk, respectively, as well as a substantial
increase in the number of research and development personnel employed by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sales</B><B></B><B>&nbsp;&amp; Marketing Expenses: </B>sales and
marketing expenses were&nbsp;&#128;15.8 million&nbsp;for 2017 compared to&nbsp;&#128;11.3 million&nbsp;for 2016, reflecting an increase of &#128;4.5&nbsp;million, or 40.3%. The increase in sales and marketing expenses resulted from an increase in
U.S. employee headcount and expenses related to the potential launch and commercialization of Viaskin Peanut in North America, as well as an increase in share-based compensation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General</B><B></B><B>&nbsp;&amp; Administrative Expenses: </B>general and administrative expenses were &#128;35.8 million&nbsp;for 2017, compared
to&nbsp;&#128;35.0 million&nbsp;for 2016. The increase in general and administrative expenses was primarily attributable to an increase in personnel-related expenses as a result of our increased global employee headcount and increased costs
associated with legal and professional services, partially offset by decreases in share-based compensation and insurance expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Net Loss: </B>net
loss was&nbsp;&#128;147.7 million&nbsp;for 2017, compared to&nbsp;&#128;114.5 million&nbsp;in 2016. Loss per share (based on the weighted average number of shares outstanding over the period) was &#128;(5.97) and &#128;(4.68) in 2017 and 2016,
respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">@DBV Technologies</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">facebook.com/DBVTechnologies</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">www.dbv-technologies.com</TD></TR></TABLE>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g551419g49i37.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About DBV Technologies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DBV Technologies is developing Viaskin<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, a proprietary technology platform with broad potential
applications in immunotherapy. Viaskin is based on epicutaneous immunotherapy, or EPIT<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, DBV&#146;s method of delivering biologically active compounds to the immune system through intact skin.
With this new class of self-administered and <FONT STYLE="white-space:nowrap">non-invasive</FONT> product candidates, the company is dedicated to safely transforming the care of food allergic patients, for whom there are no approved treatments.
DBV&#146;s food allergies programs include ongoing clinical trials of Viaskin Peanut and Viaskin Milk, and preclinical development of Viaskin Egg. DBV is also pursuing a human
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-concept</FONT></FONT> clinical study of Viaskin Milk for the treatment of Eosinophilic Esophagitis, and exploring potential applications of its platform in vaccines and other
immune diseases. DBV Technologies has global headquarters in Montrouge, France and New York, NY. Company shares are traded on segment A of Euronext Paris (Ticker: DBV, ISIN code: FR0010417345), part of the SBF120 index, and traded on the Nasdaq
Global Select Market in the form of American Depositary Shares (each representing <FONT STYLE="white-space:nowrap">one-half</FONT> of one ordinary share) (Ticker: DBVT). For more information on DBV Technologies, please visit our website: <U><FONT
STYLE="white-space:nowrap">www.dbv-technologies.com</FONT></U> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DBV Investor Relations Contact </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sara Blum Sherman </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Senior Director, Investor Relations&nbsp;&amp;
Strategy </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">+1&nbsp;212-271-0740</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><FONT STYLE="white-space:nowrap">sara.sherman@dbv-technologies.com</FONT></U> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DBV Media Contact </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Roberta Di Giorgio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Senior Director, Corporate Communications </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">+1&nbsp;917-612-2861</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><FONT STYLE="white-space:nowrap">roberta.digiorgio@dbv-technologies.com</FONT></U> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">@DBV Technologies</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">facebook.com/DBVTechnologies</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">www.dbv-technologies.com</TD></TR></TABLE>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g551419g22k72.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g551419g22k72.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!V17AI9@  34T *@    @  8=I  0
M   !    &@       9*&  <   !     +     !53DE#3T1%  !, $4 00!$
M "  5 !E &, : !N &\ ; !O &< :0!E ', ( !) &X 8P N "  5@ Q "X
M,  Q  #_VP!#  D&!P@'!@D(!P@*"@D+#18/#0P,#1L4%1 6(!TB(B ='Q\D
M*#0L)"8Q)Q\?+3TM,34W.CHZ(RL_1#\X0S0Y.C?_VP!# 0H*"@T,#1H/#QHW
M)1\E-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W
M-S<W-S<W-S?_P  1" "B Q@# 2(  A$! Q$!_\0 'P   04! 0$! 0$
M      $" P0%!@<("0H+_\0 M1   @$# P($ P4%! 0   %] 0(#  01!1(A
M,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*%A<8&1HE)B<H*2HT-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3
ME)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'B
MX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%
M!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B
M,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'
M2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:
MHJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ
M\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#@?[;U;K_:E]^-P_\ C1_;>K?]!2]_
M\"'_ ,:H45WV1R7+_P#;>K?]!2]_\"'_ ,:/[;U;_H*7O_@0_P#C5"BBR"Y?
M_MO5O^@I>_\ @0_^-']MZM_T%+W_ ,"'_P :H44607+_ /;>K?\ 04O?_ A_
M\:/[;U;_ *"E[_X$/_C5"BBR"Y?_ +;U;_H*7O\ X$/_ (T?VWJW_04O?_ A
M_P#&J%%%D%R__;>K?]!2]_\  A_\:/[;U;_H*7O_ ($/_C5"BBR"Y?\ [;U;
M_H*7O_@0_P#C1_;>K?\ 04O?_ A_\:H44607+_\ ;>K?]!2]_P# A_\ &C^V
M]6_Z"E[_ .!#_P"-4**+(+E_^V]6_P"@I>_^!#_XT?VWJW_04O?_  (?_&J%
M%%D%R_\ VWJW_04O?_ A_P#&C^V]6_Z"E[_X$/\ XU0HHL@N7_[;U;_H*7O_
M ($/_C1_;>K?]!2]_P# A_\ &J%%%D%R_P#VWJW_ $%+W_P(?_&C^V]6_P"@
MI>_^!#_XU0HHL@N7_P"V]6_Z"E[_ .!#_P"-']MZM_T%+W_P(?\ QJA119!<
MO_VWJW_04O?_  (?_&C^V]6_Z"E[_P"!#_XU0HHL@N7_ .V]6_Z"E[_X$/\
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M_P :/[;U;_H*7O\ X$/_ (U0HHL@N7_[;U;_ *"E[_X$/_C1_;>K?]!2]_\
M A_\:H44607+_P#;>K?]!2]_\"'_ ,:*H44607#O11WHIB"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 @I:04M !1110 4444 %%%% !6=J<\A,=I;G$LW5O[J]ZT
M#TK*A;.I7UP__+% H^F,G^5..Y+&Y:)A8::JJR_ZR0_PC_'_ #])5T>W.&N#
M)-)W9F//Y4_18RMF)'P99F+N?7/_ -:M"FVT] 2NC+;25ARUA*\#]0,Y4_6H
MB/[0C:.11%?P<@K_ )Z5L&LS4<0WMG<IDDN(F _B#=/RYH3;!JQ9TRY^U6X9
MN)%)60?[0JW6;:_NM8N8P>)$$F!VYY/XDUI4I;C3T"BBBD,**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^8%:D$BRHLD9RCJ&4^H/-,AM+>!0L,$:*.@50*G QTJ9<O0J"G]IH6BBBI-
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MN4)&QSC([<#\JP7\,^+(/#JZW:^,;V5Q:BZ\B1FP1MW$9+$$XZ9'6M7XZ_\
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M.0?HM'+J[] YM#O**:M.J2@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUS5VBB[#D11>T+RL=Z[6=78;.<C'0YXZ5<48IU%*XTD@HHHH&%%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 (*6BB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
IHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g551419g49i37.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g551419g49i37.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!V17AI9@  34T *@    @  8=I  0
M   !    &@       9*&  <   !     +     !53DE#3T1%  !, $4 00!$
M "  5 !E &, : !N &\ ; !O &< :0!E ', ( !) &X 8P N "  5@ Q "X
M,  Q  #_VP!#  D&!P@'!@D(!P@*"@D+#18/#0P,#1L4%1 6(!TB(B ='Q\D
M*#0L)"8Q)Q\?+3TM,34W.CHZ(RL_1#\X0S0Y.C?_VP!# 0H*"@T,#1H/#QHW
M)1\E-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W
M-S<W-S<W-S?_P  1" "H Q@# 2(  A$! Q$!_\0 'P   04! 0$! 0$
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M_P"!#_XT?VWJW_04O?\ P(?_ !JA119!<O\ ]MZM_P!!2]_\"'_QH_MO5O\
MH*7O_@0_^-4**+(+E_\ MO5O^@I>_P#@0_\ C1_;>K?]!2]_\"'_ ,:H4460
M7+_]MZM_T%+W_P "'_QH_MO5O^@I>_\ @0_^-4**+(+E_P#MO5O^@I>_^!#_
M .-']MZM_P!!2]_\"'_QJA119!<O_P!MZM_T%+W_ ,"'_P :/[;U;_H*7O\
MX$/_ (U0HHL@N7_[;U;_ *"E[_X$/_C1_;>K?]!2]_\  A_\:H44607+_P#;
M>K?]!2]_\"'_ ,:/[;U;_H*7O_@0_P#C5"BBR"Y?_MO5O^@I>_\ @0_^-']M
MZM_T%+W_ ,"'_P :H44607+_ /;>K?\ 04O?_ A_\:/[;U;_ *"E[_X$/_C5
M"BBR"Y?_ +;U;_H*7O\ X$/_ (T?VWJW_04O?_ A_P#&J%%%D%R__;>K?]!2
M]_\  A_\:/[;U;_H*7O_ ($/_C5"BBR"Y?\ [;U;_H*7O_@0_P#C1_;>K?\
M04O?_ A_\:H44607+_\ ;>K?]!2]_P# A_\ &C^V]6_Z"E[_ .!#_P"-4**+
M(+E_^V]6_P"@I>_^!#_XT?VWJW_04O?_  (?_&J%%%D%R_\ VWJW_04O?_ A
M_P#&C^V]6_Z"E[_X$/\ XU0HHL@N7_[;U;_H*7O_ ($/_C1_;>K?]!2]_P#
MA_\ &J%%%D%R_P#VWJW_ $%+W_P(?_&C^V]6_P"@I>_^!#_XU0HHL@N7_P"V
M]6_Z"E[_ .!#_P"-']MZM_T%+W_P(?\ QJA119!<O_VWJW_04O?_  (?_&C^
MV]6_Z"E[_P"!#_XU0HHL@N7_ .V]6_Z"E[_X$/\ XT?VWJW_ $%+W_P(?_&J
M%%%D%R__ &WJW_04O?\ P(?_ !H_MO5O^@I>_P#@0_\ C5"BBR"Y?_MO5O\
MH*7O_@0_^-']MZM_T%+W_P "'_QJA119!<O_ -MZM_T%+W_P(?\ QH_MO5O^
M@I>_^!#_ .-4**+(+E_^V]6_Z"E[_P"!#_XT?VWJW_04O?\ P(?_ !JA119!
M<O\ ]MZM_P!!2]_\"'_QH_MO5O\ H*7O_@0_^-4**+(+E_\ MO5O^@I>_P#@
M0_\ C1_;>K?]!2]_\"'_ ,:H44607+_]MZM_T%+W_P "'_QH_MO5O^@I>_\
M@0_^-4**+(+E_P#MO5O^@I>_^!#_ .-']MZM_P!!2]_\"'_QJA119!<O_P!M
MZM_T%+W_ ,"'_P :/[;U;_H*7O\ X$/_ (U0HHL@N7_[;U;_ *"E[_X$/_C1
M_;>K?]!2]_\  A_\:H44607+_P#;>K?]!2]_\"'_ ,:/[;U;_H*7O_@0_P#C
M5"BBR"Y?_MO5O^@I>_\ @0_^-']MZM_T%+W_ ,"'_P :H44607+_ /;>K?\
M04O?_ A_\:/[;U;_ *"E[_X$/_C5"BBR"Y?_ +;U;_H*7O\ X$/_ (T?VWJW
M_04O?_ A_P#&J%%%D%R__;>K?]!2]_\  A_\:/[;U;_H*7O_ ($/_C5"BBR"
MY?\ [;U;_H*7O_@0_P#C1_;>K?\ 04O?_ A_\:H44607+_\ ;>K?]!2]_P#
MA_\ &C^V]6_Z"E[_ .!#_P"-4**+(+E_^V]6_P"@I>_^!#_XT?VWJW_04O?_
M  (?_&J%%%D%R_\ VWJW_04O?_ A_P#&BJ%%%D%PHHHIB"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0?5:7_/Q?<SYYHKZ&_X5GH?_ #S7_ORO^%'_  K/0_\ GFO_ 'Y7_"CZW/\
MY]O[T'U6E_S\7W,^>:*^AO\ A6>A_P#/-?\ ORO^%'_"L]#_ .>:_P#?E?\
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M^MS_ .?;^]!]5I?\_%]S/GFBOH;_ (5GH?\ SS7_ +\K_A1_PK/0_P#GFO\
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M  K/0_\ GFO_ 'Y7_"CZW/\ Y]O[T'U6E_S\7W,^>:*^AO\ A6>A_P#/-?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BJ]W#]HMWA$DD188WQG##Z&L@Z'>PC-GK5WN'03GS!5))[NQG.<HO2-S?
MK-CQ_;D@/WO(X^F15.TU:>&Z6QUB-8ISQ%,OW)?IZ'_/%6=0(M;VWO,?)_JY
M#Z#M_7\J?*T[,4:D9JZ'Z'Q9$'[X<AOK6E60K#3[^0/Q;W!WJW96[Y_SZ>]:
M_P!*4M[FD=K!6;K^W^RIMPSRO_H0K2K)F<:A>QP1<PPMOE<=">P_S_2E'>X2
MV'3AO[5L!W"MN_[Y-:E9=F?M>I37/6.-?+0]CZG_ #ZU6O=6FDNFL='C$UP/
M]9(WW(OJ>Y_SSTJN5R=D1*I&"N^INT5@?V)?3C=>:U=[SR1 ?+4?E6O9P?9K
M9(3+)*4&-\ARQ^II-);.X0G*3UC8L4445)H%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJ:M5G*=U9;%TZ;3YI[_EZ!1114&P4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
B4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
